Baicalein inhibits fibronectin-induced epithelial–mesenchymal transition by decreasing activation and upregulation of calpain-2

The extracellular matrix protein fibronectin (FN) facilitates tumorigenesis and the development of breast cancer. Inhibition of the FN-induced cellular response is a potential strategy for breast cancer treatment. In the present study, we investigated the effects of the flavonoid baicalein on FN-ind...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell death & disease 2019-04, Vol.10 (5), p.341, Article 341
Hauptverfasser: Chen, Yan, Chen, Lin, Hong, Duanyang, Chen, Zongyue, Zhang, Jingyu, Fu, Lingyun, Pan, Di, Zhang, Yanyan, Xu, Yini, Gan, Shiquan, Xiao, Chaoda, Tao, Ling, Shen, Xiangchun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page 341
container_title Cell death & disease
container_volume 10
creator Chen, Yan
Chen, Lin
Hong, Duanyang
Chen, Zongyue
Zhang, Jingyu
Fu, Lingyun
Pan, Di
Zhang, Yanyan
Xu, Yini
Gan, Shiquan
Xiao, Chaoda
Tao, Ling
Shen, Xiangchun
description The extracellular matrix protein fibronectin (FN) facilitates tumorigenesis and the development of breast cancer. Inhibition of the FN-induced cellular response is a potential strategy for breast cancer treatment. In the present study, we investigated the effects of the flavonoid baicalein on FN-induced epithelial–mesenchymal transition (EMT) in MCF-10A breast epithelial cells and in a transgenic mouse MMTV-polyoma middle T antigen breast cancer model (MMTV-PyMT). Baicalein inhibited FN-induced migration, invasion, and F-actin remodeling. Baicalein also suppressed FN-induced downregulation of the epithelial markers E-cadherin and ZO-1 and upregulation of the mesenchymal markers N-cadherin, vimentin, and Snail. Further investigation revealed that calpain-2 was involved in baicalein suppression of FN-induced EMT. Baicalein significantly decreased FN-enhanced calpain-2 expression and activation by suppressing its plasma membrane localization, substrate cleavage, and degradation of its endogenous inhibitor calpastatin. Overexpression of calpain-2 in MCF-10A cells by gene transfection partially blocked the inhibitory effect of baicalein on FN-induced EMT changes. In addition, baicalein inhibited calpain-2 by decreasing FN-increased intracellular calcium ion levels and extracellular signal-regulated protein kinases activation. Baicalein significantly decreased tumor onset, growth, and pulmonary metastasis in a spontaneous breast cancer MMTV-PyMT mouse model. Baicalein also reduced the expression of FN, calpain-2, and vimentin, but increased E-cadherin expression in MMTV-PyMT mouse tumors. Overall, these results revealed that baicalein markedly inhibited FN-induced EMT by inhibiting calpain-2, thus providing novel insights into the pharmacological action and mechanism of baicalein. Baicalein may therefore possess therapeutic potential for the treatment of breast cancer though interfering with extracellular matrix–cancer cell interactions.
doi_str_mv 10.1038/s41419-019-1572-7
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6472504</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2211320268</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-2101ed12eb0cded7e6b16863e3b1a6d2649886ef0a8e7c9df3ea3470291e20a93</originalsourceid><addsrcrecordid>eNp1Uc1KHTEUDqWiYn0ANyXQ9dicZG5mZiNYqa0gdFPX4Uxy5t7I3Mw0mRHurn2GvqFPYuyotYsGQn7O9wcfYycgTkGo-mMqoYSmEHnDqpJF9YYdSlFCUdZ18_bV_YAdp3Qr8lJKyJXeZwcK8ks3-pD9-oTeYk8-cB82vvVT4p1v4xDITj4UPrjZkuM0-mlDvcf-_ufvLSUKdrPbYs-niCH5yQ-BtzvuyEbC5MOaY-bf4Z8BBsfnMdJ67pePoePZdMRsIN-xvQ77RMdP5xG7ufz8_eJrcf3ty9XF-XVhV0pPhQQB5EBSK6wjV5FuQddakWoBtZO6bOpaUyewpso2rlOEqqyEbICkwEYdsbNFd5zbLTlLIUfvzRj9FuPODOjNv5PgN2Y93BldVnIlyizw4UkgDj9mSpO5HeYYcmYjJYCSQuo6o2BB2TikFKl7cQBhHoszS3EmF2ceizNV5rx_He2F8VxTBsgFkPIorCn-tf6_6gMh_6hn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2211320268</pqid></control><display><type>article</type><title>Baicalein inhibits fibronectin-induced epithelial–mesenchymal transition by decreasing activation and upregulation of calpain-2</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>PubMed Central</source><creator>Chen, Yan ; Chen, Lin ; Hong, Duanyang ; Chen, Zongyue ; Zhang, Jingyu ; Fu, Lingyun ; Pan, Di ; Zhang, Yanyan ; Xu, Yini ; Gan, Shiquan ; Xiao, Chaoda ; Tao, Ling ; Shen, Xiangchun</creator><creatorcontrib>Chen, Yan ; Chen, Lin ; Hong, Duanyang ; Chen, Zongyue ; Zhang, Jingyu ; Fu, Lingyun ; Pan, Di ; Zhang, Yanyan ; Xu, Yini ; Gan, Shiquan ; Xiao, Chaoda ; Tao, Ling ; Shen, Xiangchun</creatorcontrib><description>The extracellular matrix protein fibronectin (FN) facilitates tumorigenesis and the development of breast cancer. Inhibition of the FN-induced cellular response is a potential strategy for breast cancer treatment. In the present study, we investigated the effects of the flavonoid baicalein on FN-induced epithelial–mesenchymal transition (EMT) in MCF-10A breast epithelial cells and in a transgenic mouse MMTV-polyoma middle T antigen breast cancer model (MMTV-PyMT). Baicalein inhibited FN-induced migration, invasion, and F-actin remodeling. Baicalein also suppressed FN-induced downregulation of the epithelial markers E-cadherin and ZO-1 and upregulation of the mesenchymal markers N-cadherin, vimentin, and Snail. Further investigation revealed that calpain-2 was involved in baicalein suppression of FN-induced EMT. Baicalein significantly decreased FN-enhanced calpain-2 expression and activation by suppressing its plasma membrane localization, substrate cleavage, and degradation of its endogenous inhibitor calpastatin. Overexpression of calpain-2 in MCF-10A cells by gene transfection partially blocked the inhibitory effect of baicalein on FN-induced EMT changes. In addition, baicalein inhibited calpain-2 by decreasing FN-increased intracellular calcium ion levels and extracellular signal-regulated protein kinases activation. Baicalein significantly decreased tumor onset, growth, and pulmonary metastasis in a spontaneous breast cancer MMTV-PyMT mouse model. Baicalein also reduced the expression of FN, calpain-2, and vimentin, but increased E-cadherin expression in MMTV-PyMT mouse tumors. Overall, these results revealed that baicalein markedly inhibited FN-induced EMT by inhibiting calpain-2, thus providing novel insights into the pharmacological action and mechanism of baicalein. Baicalein may therefore possess therapeutic potential for the treatment of breast cancer though interfering with extracellular matrix–cancer cell interactions.</description><identifier>ISSN: 2041-4889</identifier><identifier>EISSN: 2041-4889</identifier><identifier>DOI: 10.1038/s41419-019-1572-7</identifier><identifier>PMID: 31000696</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>14/19 ; 631/154/436/2388 ; 64 ; 64/60 ; 692/308/153 ; 96/109 ; 96/31 ; Actin ; Animals ; Antibodies ; Biochemistry ; Biomedical and Life Sciences ; Breast cancer ; Breast Neoplasms - drug therapy ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Butadienes - pharmacology ; Cadherins - metabolism ; Calcium (extracellular) ; Calcium (intracellular) ; Calcium - metabolism ; Calpain ; Calpain - metabolism ; Calpastatin ; Cell Biology ; Cell Culture ; Cell interactions ; Cell Line, Tumor ; E-cadherin ; Epithelial cells ; Epithelial-Mesenchymal Transition - drug effects ; Extracellular matrix ; Extracellular Signal-Regulated MAP Kinases - metabolism ; Female ; Fibronectin ; Fibronectins - metabolism ; Flavanones - pharmacology ; Flavanones - therapeutic use ; Humans ; Immunology ; Kaplan-Meier Estimate ; Life Sciences ; Localization ; Matrix protein ; Mesenchyme ; Metastases ; Mice ; Mice, Transgenic ; N-Cadherin ; Nitriles - pharmacology ; Protein kinase ; Transfection ; Transgenic mice ; Tumorigenesis ; Up-regulation ; Up-Regulation - drug effects ; Vimentin ; Zonula occludens-1 protein ; Zonula Occludens-1 Protein - metabolism</subject><ispartof>Cell death &amp; disease, 2019-04, Vol.10 (5), p.341, Article 341</ispartof><rights>The Author(s) 2019</rights><rights>The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-2101ed12eb0cded7e6b16863e3b1a6d2649886ef0a8e7c9df3ea3470291e20a93</citedby><cites>FETCH-LOGICAL-c536t-2101ed12eb0cded7e6b16863e3b1a6d2649886ef0a8e7c9df3ea3470291e20a93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472504/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472504/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,27905,27906,41101,42170,51557,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31000696$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Yan</creatorcontrib><creatorcontrib>Chen, Lin</creatorcontrib><creatorcontrib>Hong, Duanyang</creatorcontrib><creatorcontrib>Chen, Zongyue</creatorcontrib><creatorcontrib>Zhang, Jingyu</creatorcontrib><creatorcontrib>Fu, Lingyun</creatorcontrib><creatorcontrib>Pan, Di</creatorcontrib><creatorcontrib>Zhang, Yanyan</creatorcontrib><creatorcontrib>Xu, Yini</creatorcontrib><creatorcontrib>Gan, Shiquan</creatorcontrib><creatorcontrib>Xiao, Chaoda</creatorcontrib><creatorcontrib>Tao, Ling</creatorcontrib><creatorcontrib>Shen, Xiangchun</creatorcontrib><title>Baicalein inhibits fibronectin-induced epithelial–mesenchymal transition by decreasing activation and upregulation of calpain-2</title><title>Cell death &amp; disease</title><addtitle>Cell Death Dis</addtitle><addtitle>Cell Death Dis</addtitle><description>The extracellular matrix protein fibronectin (FN) facilitates tumorigenesis and the development of breast cancer. Inhibition of the FN-induced cellular response is a potential strategy for breast cancer treatment. In the present study, we investigated the effects of the flavonoid baicalein on FN-induced epithelial–mesenchymal transition (EMT) in MCF-10A breast epithelial cells and in a transgenic mouse MMTV-polyoma middle T antigen breast cancer model (MMTV-PyMT). Baicalein inhibited FN-induced migration, invasion, and F-actin remodeling. Baicalein also suppressed FN-induced downregulation of the epithelial markers E-cadherin and ZO-1 and upregulation of the mesenchymal markers N-cadherin, vimentin, and Snail. Further investigation revealed that calpain-2 was involved in baicalein suppression of FN-induced EMT. Baicalein significantly decreased FN-enhanced calpain-2 expression and activation by suppressing its plasma membrane localization, substrate cleavage, and degradation of its endogenous inhibitor calpastatin. Overexpression of calpain-2 in MCF-10A cells by gene transfection partially blocked the inhibitory effect of baicalein on FN-induced EMT changes. In addition, baicalein inhibited calpain-2 by decreasing FN-increased intracellular calcium ion levels and extracellular signal-regulated protein kinases activation. Baicalein significantly decreased tumor onset, growth, and pulmonary metastasis in a spontaneous breast cancer MMTV-PyMT mouse model. Baicalein also reduced the expression of FN, calpain-2, and vimentin, but increased E-cadherin expression in MMTV-PyMT mouse tumors. Overall, these results revealed that baicalein markedly inhibited FN-induced EMT by inhibiting calpain-2, thus providing novel insights into the pharmacological action and mechanism of baicalein. Baicalein may therefore possess therapeutic potential for the treatment of breast cancer though interfering with extracellular matrix–cancer cell interactions.</description><subject>14/19</subject><subject>631/154/436/2388</subject><subject>64</subject><subject>64/60</subject><subject>692/308/153</subject><subject>96/109</subject><subject>96/31</subject><subject>Actin</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Butadienes - pharmacology</subject><subject>Cadherins - metabolism</subject><subject>Calcium (extracellular)</subject><subject>Calcium (intracellular)</subject><subject>Calcium - metabolism</subject><subject>Calpain</subject><subject>Calpain - metabolism</subject><subject>Calpastatin</subject><subject>Cell Biology</subject><subject>Cell Culture</subject><subject>Cell interactions</subject><subject>Cell Line, Tumor</subject><subject>E-cadherin</subject><subject>Epithelial cells</subject><subject>Epithelial-Mesenchymal Transition - drug effects</subject><subject>Extracellular matrix</subject><subject>Extracellular Signal-Regulated MAP Kinases - metabolism</subject><subject>Female</subject><subject>Fibronectin</subject><subject>Fibronectins - metabolism</subject><subject>Flavanones - pharmacology</subject><subject>Flavanones - therapeutic use</subject><subject>Humans</subject><subject>Immunology</subject><subject>Kaplan-Meier Estimate</subject><subject>Life Sciences</subject><subject>Localization</subject><subject>Matrix protein</subject><subject>Mesenchyme</subject><subject>Metastases</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>N-Cadherin</subject><subject>Nitriles - pharmacology</subject><subject>Protein kinase</subject><subject>Transfection</subject><subject>Transgenic mice</subject><subject>Tumorigenesis</subject><subject>Up-regulation</subject><subject>Up-Regulation - drug effects</subject><subject>Vimentin</subject><subject>Zonula occludens-1 protein</subject><subject>Zonula Occludens-1 Protein - metabolism</subject><issn>2041-4889</issn><issn>2041-4889</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1Uc1KHTEUDqWiYn0ANyXQ9dicZG5mZiNYqa0gdFPX4Uxy5t7I3Mw0mRHurn2GvqFPYuyotYsGQn7O9wcfYycgTkGo-mMqoYSmEHnDqpJF9YYdSlFCUdZ18_bV_YAdp3Qr8lJKyJXeZwcK8ks3-pD9-oTeYk8-cB82vvVT4p1v4xDITj4UPrjZkuM0-mlDvcf-_ufvLSUKdrPbYs-niCH5yQ-BtzvuyEbC5MOaY-bf4Z8BBsfnMdJ67pePoePZdMRsIN-xvQ77RMdP5xG7ufz8_eJrcf3ty9XF-XVhV0pPhQQB5EBSK6wjV5FuQddakWoBtZO6bOpaUyewpso2rlOEqqyEbICkwEYdsbNFd5zbLTlLIUfvzRj9FuPODOjNv5PgN2Y93BldVnIlyizw4UkgDj9mSpO5HeYYcmYjJYCSQuo6o2BB2TikFKl7cQBhHoszS3EmF2ceizNV5rx_He2F8VxTBsgFkPIorCn-tf6_6gMh_6hn</recordid><startdate>20190418</startdate><enddate>20190418</enddate><creator>Chen, Yan</creator><creator>Chen, Lin</creator><creator>Hong, Duanyang</creator><creator>Chen, Zongyue</creator><creator>Zhang, Jingyu</creator><creator>Fu, Lingyun</creator><creator>Pan, Di</creator><creator>Zhang, Yanyan</creator><creator>Xu, Yini</creator><creator>Gan, Shiquan</creator><creator>Xiao, Chaoda</creator><creator>Tao, Ling</creator><creator>Shen, Xiangchun</creator><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20190418</creationdate><title>Baicalein inhibits fibronectin-induced epithelial–mesenchymal transition by decreasing activation and upregulation of calpain-2</title><author>Chen, Yan ; Chen, Lin ; Hong, Duanyang ; Chen, Zongyue ; Zhang, Jingyu ; Fu, Lingyun ; Pan, Di ; Zhang, Yanyan ; Xu, Yini ; Gan, Shiquan ; Xiao, Chaoda ; Tao, Ling ; Shen, Xiangchun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-2101ed12eb0cded7e6b16863e3b1a6d2649886ef0a8e7c9df3ea3470291e20a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>14/19</topic><topic>631/154/436/2388</topic><topic>64</topic><topic>64/60</topic><topic>692/308/153</topic><topic>96/109</topic><topic>96/31</topic><topic>Actin</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Butadienes - pharmacology</topic><topic>Cadherins - metabolism</topic><topic>Calcium (extracellular)</topic><topic>Calcium (intracellular)</topic><topic>Calcium - metabolism</topic><topic>Calpain</topic><topic>Calpain - metabolism</topic><topic>Calpastatin</topic><topic>Cell Biology</topic><topic>Cell Culture</topic><topic>Cell interactions</topic><topic>Cell Line, Tumor</topic><topic>E-cadherin</topic><topic>Epithelial cells</topic><topic>Epithelial-Mesenchymal Transition - drug effects</topic><topic>Extracellular matrix</topic><topic>Extracellular Signal-Regulated MAP Kinases - metabolism</topic><topic>Female</topic><topic>Fibronectin</topic><topic>Fibronectins - metabolism</topic><topic>Flavanones - pharmacology</topic><topic>Flavanones - therapeutic use</topic><topic>Humans</topic><topic>Immunology</topic><topic>Kaplan-Meier Estimate</topic><topic>Life Sciences</topic><topic>Localization</topic><topic>Matrix protein</topic><topic>Mesenchyme</topic><topic>Metastases</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>N-Cadherin</topic><topic>Nitriles - pharmacology</topic><topic>Protein kinase</topic><topic>Transfection</topic><topic>Transgenic mice</topic><topic>Tumorigenesis</topic><topic>Up-regulation</topic><topic>Up-Regulation - drug effects</topic><topic>Vimentin</topic><topic>Zonula occludens-1 protein</topic><topic>Zonula Occludens-1 Protein - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Yan</creatorcontrib><creatorcontrib>Chen, Lin</creatorcontrib><creatorcontrib>Hong, Duanyang</creatorcontrib><creatorcontrib>Chen, Zongyue</creatorcontrib><creatorcontrib>Zhang, Jingyu</creatorcontrib><creatorcontrib>Fu, Lingyun</creatorcontrib><creatorcontrib>Pan, Di</creatorcontrib><creatorcontrib>Zhang, Yanyan</creatorcontrib><creatorcontrib>Xu, Yini</creatorcontrib><creatorcontrib>Gan, Shiquan</creatorcontrib><creatorcontrib>Xiao, Chaoda</creatorcontrib><creatorcontrib>Tao, Ling</creatorcontrib><creatorcontrib>Shen, Xiangchun</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cell death &amp; disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Yan</au><au>Chen, Lin</au><au>Hong, Duanyang</au><au>Chen, Zongyue</au><au>Zhang, Jingyu</au><au>Fu, Lingyun</au><au>Pan, Di</au><au>Zhang, Yanyan</au><au>Xu, Yini</au><au>Gan, Shiquan</au><au>Xiao, Chaoda</au><au>Tao, Ling</au><au>Shen, Xiangchun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Baicalein inhibits fibronectin-induced epithelial–mesenchymal transition by decreasing activation and upregulation of calpain-2</atitle><jtitle>Cell death &amp; disease</jtitle><stitle>Cell Death Dis</stitle><addtitle>Cell Death Dis</addtitle><date>2019-04-18</date><risdate>2019</risdate><volume>10</volume><issue>5</issue><spage>341</spage><pages>341-</pages><artnum>341</artnum><issn>2041-4889</issn><eissn>2041-4889</eissn><abstract>The extracellular matrix protein fibronectin (FN) facilitates tumorigenesis and the development of breast cancer. Inhibition of the FN-induced cellular response is a potential strategy for breast cancer treatment. In the present study, we investigated the effects of the flavonoid baicalein on FN-induced epithelial–mesenchymal transition (EMT) in MCF-10A breast epithelial cells and in a transgenic mouse MMTV-polyoma middle T antigen breast cancer model (MMTV-PyMT). Baicalein inhibited FN-induced migration, invasion, and F-actin remodeling. Baicalein also suppressed FN-induced downregulation of the epithelial markers E-cadherin and ZO-1 and upregulation of the mesenchymal markers N-cadherin, vimentin, and Snail. Further investigation revealed that calpain-2 was involved in baicalein suppression of FN-induced EMT. Baicalein significantly decreased FN-enhanced calpain-2 expression and activation by suppressing its plasma membrane localization, substrate cleavage, and degradation of its endogenous inhibitor calpastatin. Overexpression of calpain-2 in MCF-10A cells by gene transfection partially blocked the inhibitory effect of baicalein on FN-induced EMT changes. In addition, baicalein inhibited calpain-2 by decreasing FN-increased intracellular calcium ion levels and extracellular signal-regulated protein kinases activation. Baicalein significantly decreased tumor onset, growth, and pulmonary metastasis in a spontaneous breast cancer MMTV-PyMT mouse model. Baicalein also reduced the expression of FN, calpain-2, and vimentin, but increased E-cadherin expression in MMTV-PyMT mouse tumors. Overall, these results revealed that baicalein markedly inhibited FN-induced EMT by inhibiting calpain-2, thus providing novel insights into the pharmacological action and mechanism of baicalein. Baicalein may therefore possess therapeutic potential for the treatment of breast cancer though interfering with extracellular matrix–cancer cell interactions.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>31000696</pmid><doi>10.1038/s41419-019-1572-7</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2041-4889
ispartof Cell death & disease, 2019-04, Vol.10 (5), p.341, Article 341
issn 2041-4889
2041-4889
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6472504
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Springer Nature OA Free Journals; Nature Free; PubMed Central
subjects 14/19
631/154/436/2388
64
64/60
692/308/153
96/109
96/31
Actin
Animals
Antibodies
Biochemistry
Biomedical and Life Sciences
Breast cancer
Breast Neoplasms - drug therapy
Breast Neoplasms - mortality
Breast Neoplasms - pathology
Butadienes - pharmacology
Cadherins - metabolism
Calcium (extracellular)
Calcium (intracellular)
Calcium - metabolism
Calpain
Calpain - metabolism
Calpastatin
Cell Biology
Cell Culture
Cell interactions
Cell Line, Tumor
E-cadherin
Epithelial cells
Epithelial-Mesenchymal Transition - drug effects
Extracellular matrix
Extracellular Signal-Regulated MAP Kinases - metabolism
Female
Fibronectin
Fibronectins - metabolism
Flavanones - pharmacology
Flavanones - therapeutic use
Humans
Immunology
Kaplan-Meier Estimate
Life Sciences
Localization
Matrix protein
Mesenchyme
Metastases
Mice
Mice, Transgenic
N-Cadherin
Nitriles - pharmacology
Protein kinase
Transfection
Transgenic mice
Tumorigenesis
Up-regulation
Up-Regulation - drug effects
Vimentin
Zonula occludens-1 protein
Zonula Occludens-1 Protein - metabolism
title Baicalein inhibits fibronectin-induced epithelial–mesenchymal transition by decreasing activation and upregulation of calpain-2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T05%3A10%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Baicalein%20inhibits%20fibronectin-induced%20epithelial%E2%80%93mesenchymal%20transition%20by%20decreasing%20activation%20and%20upregulation%20of%20calpain-2&rft.jtitle=Cell%20death%20&%20disease&rft.au=Chen,%20Yan&rft.date=2019-04-18&rft.volume=10&rft.issue=5&rft.spage=341&rft.pages=341-&rft.artnum=341&rft.issn=2041-4889&rft.eissn=2041-4889&rft_id=info:doi/10.1038/s41419-019-1572-7&rft_dat=%3Cproquest_pubme%3E2211320268%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2211320268&rft_id=info:pmid/31000696&rfr_iscdi=true